Related Experiment Video
Updated: Jun 11, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Sickle Cell Disease
Joachim B Kunz1, Laura Tagliaferri1
1Department of Pediatric Oncology, Hematology and Immunology, Hopp-Children's Cancer Center (KiTZ) Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.
Sickle cell disease (SCD), a common inherited blood disorder, is rising in Europe. Current treatments are limited, necessitating new therapeutic strategies for patients.
Area of Science:
- Hematology
- Genetics
- Pharmacology
Background:
- Sickle cell disease (SCD) is a prevalent global hereditary blood disorder.
- Increasing migration is leading to a higher prevalence of SCD in Europe.
- The pathophysiology involves sickle hemoglobin polymerization, causing hemolysis, vasoocclusion, and organ damage.
Purpose of the Study:
- To highlight the current treatment landscape for sickle cell disease.
- To emphasize the need for expanded access to existing therapies.
- To advocate for the development of novel treatment options and drug combinations for SCD.
Main Methods:
- Review of current therapeutic approaches for SCD.
- Analysis of approved disease-modifying drugs and their limitations.
- Discussion of curative options like stem cell transplantation and gene therapy, noting accessibility issues.
Main Results:
- Only two disease-modifying drugs are approved in Europe for SCD.
- Transfusion therapy is a primary treatment for severe SCD complications.
- Curative options are limited due to cost and donor availability.
Conclusions:
- There is a critical need for improved patient access to existing SCD treatments.
- Further research into drug combinations is essential.
- Development of new therapeutic strategies is required to address unmet needs in SCD management.
Related Concept Videos
Multiple Allele Traits
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
iPS Cell Differentiation
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

